Assessment of symptoms and comorbidities is important for developing individualized care plans for patients with long COVID.
Read our answers to key issues about SARS-CoV-2 testing and patient-specific risk stratification for determining COVID-19 treatment.
Read my answers to key issues about treatment recommendations and drug therapy considerations for nonhospitalized patients with acute COVID-19.
Read our answers to key issues about the individualized management of patients experiencing long COVID.
Learn from one patient about the challenges with long COVID and what she would like healthcare professionals to know about her experiences.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.